Market News & Insights
Market News & Insights

Johnson & Johnson results beat expectations

Klavs Valters
9/2/2024
0 min read
Share this post
Copy URL

Johnson & Johnson (NYSE: JNJ) reported Q4 2023 and full year financial results before the market open in the US on Tuesday to kick off another week of earnings. US pharmaceutical and consumer goods company reported revenue of $21.395 billion for the last quarter of 2023, beating analyst estimate of $21.022 billion. Revenue grew by 7.3% vs. the same quarter in 2022.

Earnings per share (EPS) was reported at $2.29 per share vs. $2.281 per share expected. EPS was up by 11.7% year-over-year. The company achieved revenue of $85.159 billion in 2023 – up 6.5% vs. 2022.

EPS reached $5.20 per share – down by 15.3% from 2022. Company overview Founded: 1886 Headquarters: Johnson and Johnson Plaza, New Brunswick, New Jersey, United States Number of employees: 130,000 (2023) Industry: Pharmaceutical, Medical Technology Key people: Joaquin Duato (Chairman & CEO) CEO commentary "Johnson & Johnson’s full year 2023 results reflect the breadth and competitiveness of our business and our relentless focus on delivering for patients. We have entered 2024 from a position of strength, and I am confident in our ability to lead the next wave of health innovation," Joaquin Duato, CEO of Johnson & Johnson said in a statement.

Stock reaction Shares of Johnson & Johnson were down by around 1% during Tuesday’s session after the latest results were announced, trading at $160.02 a share. Stock performance 5 day: -0.38% 1 month: +2.41% 3 months: +5.74% Year-to-date: +2.02% 1 year: -4.99% Johnson & Johnson stock price targets Cantor Fitzgerald: $215 Raymond James: $175 Wells Fargo & Company: $163 UBS Group: $180 Royal Bank of Canada: $178 Morgan Stanley: $171 Barclays: $162 HSBC: $175 Atlantic Securities: $170 Credit Suisse Group: $175 Stifel Nicolaus: $175 JP Morgan Chase & Co.: $180 Citigroup: $185 Guggenheim: $161 Johnson & Johnson is the 20th largest company in the world with a market cap of $384.14 billion. You can trade Johnson & Johnson (NYSE: JNJ) and many other stocks from the NYSE, NASDAQ, HKEX and ASX with GO Markets as a Share CFD on the MetaTrader 5 platform.

To find out more, go to "Trading" then select "Share CFDs". GO Markets offers pre-market and after-market trading on popular US Share CFDs. Why trade during extended hours?

Volatility never sleeps. Trade over earnings releases as they happen outside of main trading hours Reduce your risk and hedge your existing positions ahead of a new trading day Extended trading hours on popular US stocks means extended opportunities Sources: Johnson & Johnson, TradingView, MarketWatch, MarketBeat, CompaniesMarketCap

Related Articles

Recent Articles